Article L.233-8-II of Commercial Law (Code de commerce) and
Article 223-16 of the General Regulation of the French Financial Markets Authority
(AMF – Autorité des Marchés Financiers)
Press release
Avignon, November 4th, 2011
31.10.2011
|
Total number of outstanding shares forming the capital
|
7,705,580 |
|
Total number of outstanding shares forming the capital
|
6,318,272 |
|
Number of shares with double voting rights |
86,641 |
|
Total number of gross voting rights |
6,404,913 |
|
Number of shares without voting rights
|
- 2,540 |
|
Total number of exercisable voting rights* |
6,402,373 |
*Real number of voting rights = total number of voting rights – number of shares without voting rights
If you would like to receive FINANCIAL information about Naturex by e-mail, go to: www.naturex.fr
Naturex has been listed since October 1996 on NYSE Euronext Paris, Compartment B (MidCaps)
Number of shares comprising the capital: 7,705,580
Naturex is a component of the CAC Small and Gaïa indexes. TICKER: NRX - Reuters : NATU.PA - Bloomberg : NRX:FP |
About Naturex
NATUREX is the global leader in specialty plant-based natural ingredients.
The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets specialty plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
NATUREX's head office is based in Avignon. The company employs more than 1,000 people with high-performance manufacturing operations across 13 sites in Europe (France, Italy, Spain, the United Kingdom and Switzerland), as well as in Morocco, the United States, Brazil and Australia. It also has a global presence through a dedicated network of sales offices in 18 countries (France, Italy, Spain, the United Kingdom, Belgium, Germany, Russia, U.A.E., Thailand, Singapore, Japan, China, Korea, Australia, the United States, Canada, Brazil and Mexico).
NATUREX's development is supported by positive underlying trends linked to a fast-growing demand for natural products and its capacity to provide manufacturers customised solutions to meet the requirements of their end consumers. The Group's strength lies in its positioning with specific products which constitute niche markets, supported by strong sourcing capacity and sustained research & development.
| • Contacts | |
| Jacques Dikansky President and Chief Executive Officer Tel.: +33 (0)4 90 23 96 89 naturex@naturex.com |
Thierry Lambert Vice-President and Chief Financial Officer Tel.: +33 (0)4 90 23 96 89 t.lambert@naturex.com |
| Carole Alexandre Investor Relations Tel.: +33 (0)4 90 23 78 28 c.alexandre@naturex.com |
Anne Catherine Bonjour Actus Finance Press Relations Tel.: +33 (0)1 53 67 36 93 acbonjour@actus.fr |
